26 September 2023

REIG JOFRE appointed Alex Sanfeliu as the new Global Head of Pharmaceutical Technologies business unit

27 July 2023

REIG JOFRE submits press release on the results of the second quarter of 2023

30 June 2023

Reig Jofre and Zendal appointed by the EU to ensure vaccine production capacity in Europe in case of future health emergencies

25 May 2023

REIG JOFRE joins FARMAMUNDI’s Humanitarian Action and Emergency Fund

28 February 2023

Reig Jofre convenes its 2023 General Shareholders´ Meeting

28 February 2023

REIG JOFRE submits results note on fourth quarter of 2022

13 December 2022

REIG JOFRE has successfully completed the co-development of TRIFERTY-ATM®, a food supplement that contributes to male fertility

8 November 2022

REIG JOFRE launches a medicinal nail lacquer for onychomycosis with Ciclotech® the new patented trans-ungueal release technology

2 November 2022

REIG JOFRE submits press release on the global license agreement reached by Syna Therapeutics

28 October 2022

REIG JOFRE submits results note on third quarter of 2022

7 September 2022

FORTÉ PHARMA, REIG JOFRE’s brand of food supplements launches its E-commerce in China

26 July 2022

Reig Jofre submits results note on second quarter of 2022

25 July 2022

Reig Jofre informs on the start date of the trading of the new shares within its scrip dividend

12 July 2022

Reig Jofre informs on the bonus-shares capital increase and the new shares to be issued for its scrip dividend

14 June 2022

Execution of the scrip dividend

9 June 2022

Reig Jofre informs on the Scrip Dividend Conditions

23 May 2022

Reig Jofre launches Regenail® topical solution for structural nail alterations

28 February 2022

Reig Jofre submits results note on fourth quarter of 2021

15 November 2021

Bioglan and Stada partner to increase capacity to meet rising demand for Parkinson’s treatment

29 October 2021

Reig Jofre submits results note on third quarter of 2021